Accessibility Menu
Biohaven Stock Quote

Biohaven (NYSE: BHVN)

$16.50
(-6.9%)
-1.23
Price as of October 22, 2025, 2:14 p.m. ET

KEY DATA POINTS

Current Price
$16.5
Daily Change
(-6.9%) $1.23
Day's Range
$16.5 - $17.79
Previous Close
$17.73
Open
$17.5
Beta
1.56
Volume
1,253,593
Average Volume
2,277,987
Market Cap
1.9B
Market Cap / Employee
$17.73M
52wk Range
$12.79 - $54.98
Revenue
-
Gross Margin
-
Dividend Yield
N/A
EPS
-$7.66
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Biohaven Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
BHVN-65.47%N/AN/A+143%
S&P+15.06%+95.03%+14.29%+82%

Biohaven Company Info

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$0.00M0.0%
Gross Profit-$1.06M-8.5%
Market Cap$1.44B-53.0%
Market Cap / Employee$5.63M0.0%
Employees2567.1%
Net Income-$198.15M38.0%
EBITDA-$210.64M36.7%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$166.05M-30.6%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$286.87M995.2%
Short Term Debt$4.70M32.3%

Ratios

Q2 2025YOY Change
Return On Assets-135.38%1.7%
Return On Invested Capital-309.53%31.0%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$168.17M1.5%
Operating Free Cash Flow-$167.94M-0.1%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book12.0311.225.755.55-41.06%
Price to Tangible Book Value12.6811.976.036.01-40.38%
Enterprise Value to EBITDA-24.64-17.60-9.80-6.32-20.33%
Return on Equity-265.5%-198.8%-316.8%-295.9%52.80%
Total Debt$28.99M$36.58M$35.51M$291.56M880.27%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.